GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (OTCPK:SNNUF) » Definitions » Revenue

Smith & Nephew (Smith & Nephew) Revenue

: $5,549 Mil (TTM As of Dec. 2023)
View and export this data going back to 2009. Start your Free Trial

Smith & Nephew's revenue for the six months ended in Dec. 2023 was $2,815 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $5,549 Mil. Smith & Nephew's Revenue per Share for the six months ended in Dec. 2023 was $3.22. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $6.35.

During the past 12 months, the average Revenue per Share Growth Rate of Smith & Nephew was 2.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Smith & Nephew's highest 3-Year average Revenue per Share Growth Rate was 37.90% per year. The lowest was -9.30% per year. And the median was 3.25% per year.


Smith & Nephew Revenue Historical Data

The historical data trend for Smith & Nephew's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,138.00 4,560.00 5,212.00 5,215.00 5,549.00

Smith & Nephew Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,613.00 2,600.00 2,615.00 2,734.00 2,815.00

Competitive Comparison

For the Medical Devices subindustry, Smith & Nephew's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smith & Nephew Revenue Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Revenue distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Revenue falls into.



Smith & Nephew Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $5,549 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Smith & Nephew  (OTCPK:SNNUF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Smith & Nephew Revenue Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Smith & Nephew (Smith & Nephew) Business Description

Traded in Other Exchanges
Address
Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew (Smith & Nephew) Headlines

From GuruFocus

Smith & Nephew: A Medical Equipment Opportunity

By The City Letter 08-09-2022

Smith & Nephew Is Reverting to Fair Value

By Praveen Chawla 01-25-2023